Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 6198 participants.

Also called NCT01101035

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 6,198 participants (enrolled count) (from the registry)
Sponsor
  • Takeda Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01101035
  • WHO UTN U1111-1114-4194
Other papers using this trial's data
  • Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout The New England journal of medicine, 2018-03-29 DOI, PubMed 29527974
  • Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities American heart journal, 2012-07 DOI, PubMed 22795277
  • Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial Arthritis & rheumatology (Hoboken, N.J.), 2022-09 DOI, PubMed 35536764, PMC9541704 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Mexico (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01101035. Randomized; quadruple masking; primary purpose treatment. Start 2010-04-23 (actual); primary completion 2017-05-15 (actual). Results posted on 2018-06-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
Acronym
CARES
Condition
Cardiovascular Disease
Intervention (Drug)
Febuxostat
Intervention (Drug)
Allopurinol
Lead sponsor
Takeda (class: industry)

Record details

Record id
cardio:ct-nct01101035
Content hash
aea5c25aa80c1db2fd8fdefba36d5e3d48fa69758cd812fab8f966c3da0ae7e8